Boston Scientific Corporation vs C.H. Robinson Worldwide, Inc. — how do they compare? Boston Scientific Corporation trades at $51 (market cap $71.46B), while C.H. Robinson Worldwide, Inc. trades at $144.86 (market cap $17.33B). The key difference: Boston Scientific Corporation is far larger — about 4.1× C.H. Robinson Worldwide, Inc.'s market cap, and C.H. Robinson Worldwide, Inc. pays a 1.7% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | CHRW | |
|---|---|---|
Market Cap | $71.46B | $17.33B |
Sector | Health | Industrials |
52-Week High | $108.14 | $209.42 |
52-Week Low | $42.63 | $118.77 |
Enterprise Value | $83.55B | $19.15B |
Dividend Yield | — | 1.7% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (57% of 2021 net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm also operates a large air and ocean forwarding division (34%), which has grown organically and via tuck-in acquisitions. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
Read more on CHRW →